Vertex Pharma (VRTX) Stock Declines on news CFO Thomas Graney will Leave


The biotech firm, Vertex Pharma, stock is down today on the news that Thomas Graney will leave the company.

Ian F. Smith, age 52, executive vice president and chief operating officer and former chief financial officer, assumed the additional role of interim chief financial officer on December 13, 2018.

Mr. Graney will continue as an employee and assist in the transition through February 2019.

Vertex Pharma (VRTX) is down 1.5% early after the company announced that on December 13, 2018, Thomas Graney notified us he is resigning as our chief financial officer effective immediately.


Please enter your comment!
Please enter your name here